Consensus on biomarkers for neuroendocrine tumour disease
about
Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Advance in microRNA as a potential biomarker for early detection of pancreatic cancerNon-functioning pancreatic neuroendocrine tumors: Surgery or observation?Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Neuroendocrine, goblet cell and mixed adeno-neuroendocrine tumours of the appendix: updates, clinical applications and the future.Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements.Principles of diagnosis and management of neuroendocrine tumours.Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.Gastroenteropancreatic neuroendocrine tumours: an overview.Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration.Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasmaHistone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.Pro (With Caution): Extended oncologic indications in liver transplantation.Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.Surgical Therapy of Sporadic Pancreatic Neuroendocrine Neoplasias G1/G2.A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis.Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.miR-126 affects the invasion and migration of glioma cells through GATA4.The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.Therapy: The role of liquid biopsies to manage and predict PRRT for NETs.Effect of A549 neuroendocrine differentiation on cytotoxic immune response.Molecular Imaging in Oncology Using Positron Emission Tomography.Current Standards and Recent Advances in Biomarkers of Major Endocrine TumorsDevelopment of predictive prognostic nomogram for NECs of rectum on population-based explorationENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin AnaloguesCell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations
P2860
Q28078610-41FAA2D3-77E3-41F7-B1A4-A2DF665D82A3Q28079105-CF6C28C0-A415-487B-A672-2889327646FAQ33573118-86EA1AA7-97F1-478B-AF61-DC2FAB5C16DEQ33656484-E98450BA-7D8C-4123-A855-0514674B1BF2Q38771260-AB65D525-9E4B-404E-9F80-54B0635F674AQ38910448-393DD0E3-A8F1-4FF8-B80C-9F828B042BBCQ39225250-F7251409-E70C-42E4-906C-B5F7F847CECFQ39342352-9B2CC9C5-7BA0-4A7E-AD9A-E675819DAA9CQ40890420-083ADDD5-79FD-473C-8AC1-74652E04E96EQ41443088-506AEBE6-53BA-450A-915D-A9D8A2DD3688Q41552378-53BE835D-0C4E-4A07-82FC-3B7A2FBD5231Q42378482-38624B9F-920B-418E-8277-9471DE4E2083Q47217530-4518E78F-5016-457C-96EB-9872FEA67CB8Q47222421-CCAA709C-2EC6-442F-943D-E9B549BF74BBQ47873167-2878C0BE-516C-47E2-BFB7-4B07EC8344D1Q48106836-12F75D90-4D99-458B-BC47-EFE26C915017Q49612081-CA84EB32-93BA-40E2-A599-EC3CF4E801F4Q50318253-CF17CB00-E026-44B2-A122-19818B3A228EQ50767864-ED80BC03-4D8D-475C-BD6F-E6BD09124E4DQ51532367-9DC5050A-841A-4EE4-9525-C20E4A433885Q51555000-503BFD16-0B9E-40BF-A128-E42A3906232DQ54120525-298CB133-AC43-41AA-A42F-DCBD1204593FQ55032457-35AFC78B-B592-47F3-94AA-9B167FC63A07Q55182174-3BB73B0F-D86B-4E9D-901E-F215A9433252Q57158952-B68C7ACE-FE25-41A1-B816-9FAB0C9E7215Q57822714-4E1A456A-CD27-4FE2-9CD0-E3A42141B8C6Q57990732-B0D26178-89F4-47C7-8121-1A12DAE5C3F1Q59137752-7C4E42A8-A1A6-4FE8-B671-5E55C9F182DF
P2860
Consensus on biomarkers for neuroendocrine tumour disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus on biomarkers for neuroendocrine tumour disease
@en
Consensus on biomarkers for neuroendocrine tumour disease.
@nl
type
label
Consensus on biomarkers for neuroendocrine tumour disease
@en
Consensus on biomarkers for neuroendocrine tumour disease.
@nl
prefLabel
Consensus on biomarkers for neuroendocrine tumour disease
@en
Consensus on biomarkers for neuroendocrine tumour disease.
@nl
P2093
P2860
P1433
P1476
Consensus on biomarkers for neuroendocrine tumour disease
@en
P2093
Andrea Frilling
Anthony Heaney
David C Metz
David Klimstra
Dik Kwekkeboom
Edward Wolin
Irvin M Modlin
James Goldenring
Jonathan Strosberg
P2860
P304
P356
10.1016/S1470-2045(15)00186-2
P577
2015-09-01T00:00:00Z